ERBB2 and neoplasm: Levels of phosphorylated p65 have been reported to correlate with HER2 expression, tumour size, grade and presence of metastases in a cohort of 57 patients [15] and high DNA binding activity of p50 was associated with decreased disease free survival in a cohort of 81 cases [17].